Medical Properties Trust Inc.
Find Ratings ReportsMEDICAL PROPERTIES TRUST's gross profit margin for the fourth quarter of its fiscal year 2023 has significantly decreased when compared to the same period a year ago. Sales and net income fell significantly, underperforming compared to the average company in its subsector.
During the same period, stockholders' equity ("net worth") has decreased by 11.18% from the same quarter last year.
STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. To learn more visit www.TheStreetRatings.com.
Income Statement | Q4 FY23 | Q4 FY22 |
---|---|---|
Net Sales ($mil) | 234.74 | 387.68 |
EBITDA ($mil) | 0.0 | 0.0 |
EBIT ($mil) | -159.62 | -27.32 |
Net Income ($mil) | -663.94 | -140.47 |
Balance Sheet | Q4 FY23 | Q4 FY22 |
---|---|---|
Cash & Equiv. ($mil) | 255.95 | 241.54 |
Total Assets ($mil) | 18304.84 | 19658.0 |
Total Debt ($mil) | 10167.99 | 10371.94 |
Equity ($mil) | 7631.6 | 8592.84 |
Profitability | Q4 FY23 | Q4 FY22 |
---|---|---|
Gross Profit Margin | -55.15 | 4.02 |
EBITDA Margin | 0.0 | 0.0 |
Operating Margin | -68.0 | -7.05 |
Sales Turnover | 0.07 | 0.08 |
Return on Assets | -3.04 | 4.59 |
Return on Equity | -7.29 | 10.5 |
Debt | Q4 FY23 | Q4 FY22 |
---|---|---|
Current Ratio | 0.0 | 0.0 |
Debt/Capital | 0.57 | 0.55 |
Interest Expense | 102.3 | 92.05 |
Interest Coverage | -1.56 | -0.3 |
Share Data | Q4 FY23 | Q4 FY22 |
---|---|---|
Shares outstanding (mil) | 598.99 | 597.48 |
Div / share | 0.15 | 0.29 |
EPS | -1.11 | -0.24 |
Book value / share | 12.74 | 14.38 |
Institutional Own % | n/a | n/a |
Avg Daily Volume | 2.2481336E7 | 1.4789398E7 |
SELL. The current P/E ratio is negative, which has no meaningful value in the assessment of premium or discount valuation, it simply displays that the company has negative earnings. For additional comparison, its price-to-book ratio of 0.33 indicates a significant discount versus the S&P 500 average of 4.68 and a significant discount versus the subsector average of 6.43. The price-to-sales ratio is well below both the S&P 500 average and the subsector average, indicating a discount. After reviewing these and other key valuation criteria, MEDICAL PROPERTIES TRUST proves to trade at a discount to investment alternatives.
Price/Earnings |
|
Price/Cash Flow |
| |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
MPW NM | Peers 49.19 | MPW 4.97 | Peers 18.58 | |||||||||||||||||||||
Neutral. The absence of a valid P/E ratio happens when a stock can not be valued on the basis of a negative stream of earnings. MPW's P/E is negative making this valuation measure meaningless. |
Discount. The P/CF ratio, a stock’s price divided by the company's cash flow from operations, is useful for comparing companies with different capital requirements or financing structures. MPW is trading at a significant discount to its peers. |
|||||||||||||||||||||||
Price/Projected Earnings |
|
Price to Earnings/Growth |
|
|||||||||||||||||||||
MPW 7.64 | Peers 40.04 | MPW NA | Peers 5.86 | |||||||||||||||||||||
Discount. A lower price-to-projected earnings ratio than its peers can signify a less expensive stock or lower future growth expectations. MPW is trading at a significant discount to its peers. |
Neutral. The PEG ratio is the stock’s P/E divided by the consensus estimate of long-term earnings growth. Faster growth can justify higher price multiples. Ratio not available. |
|||||||||||||||||||||||
Price/Book |
|
Earnings Growth |
|
|||||||||||||||||||||
MPW 0.33 | Peers 6.43 | MPW -162.66 | Peers -7.55 | |||||||||||||||||||||
Discount. A lower price-to-book ratio makes a stock more attractive to investors seeking stocks with lower market values per dollar of equity on the balance sheet. MPW is trading at a significant discount to its peers. |
Lower. Elevated earnings growth rates can lead to capital appreciation and justify higher price-to-earnings ratios. However, MPW is expected to significantly trail its peers on the basis of its earnings growth rate. |
|||||||||||||||||||||||
Price/Sales |
|
Sales Growth |
|
|||||||||||||||||||||
MPW 1.85 | Peers 7.79 | MPW -14.21 | Peers 11.68 | |||||||||||||||||||||
Discount. In the absence of P/E and P/B multiples, the price-to-sales ratio can display the value investors are placing on each dollar of sales. MPW is trading at a significant discount to its subsector on this measurement. |
Lower. A sales growth rate that trails the subsector implies that a company is losing market share. MPW significantly trails its peers on the basis of sales growth. |
|||||||||||||||||||||||